×
Back to Agenda
S32 : Optimizing Clinical Trials: Rethinking the “Norms” of Clinical Operations in Japan - Past Assumptions and Future Directions
Session Chair(s)
Kazuyoshi Nanjou
Associate Director, Takeda Pharmaceutical Company Limited., Japan
Speaker(s)
Kazuhiko Mori, PHD, MSC
Business Manager, "Toyama, the Silicon Valley of Medicine" Creative Consortium Management Office, Japan
Kaori Watanabe, MPHARM
CRC, Clinical Research Promotion Center, The University of Tokyo Hospital, Japan
Yoko Kurose, MPHARM
Senior Manager, Monitoring Group,Clinical Operations, Development Japan, Pfizer R&D Japan, Japan
Have an account?